From total blood exchange to erythrocytapheresis and back to treat complications of sickle cell disease

Transfusion

Volumn 57, Issue 9, 2017, Pages 2277-2280

  Ballas, Samir K ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; APHERESIS DEVICE; BLOOD VESSEL OCCLUSION; CLINICAL EFFECTIVENESS; COMPLICATION; ERYTHROCYTAPHERESIS; HUMAN; NOTE; PLASMA EXCHANGE; PLASMA FACTOR; SICKLE CELL ANEMIA; ANEMIA, SICKLE CELL; BLOOD VISCOSITY; CYTAPHERESIS; DISEASE MANAGEMENT; ERYTHROCYTE; EXCHANGE BLOOD TRANSFUSION; PROCEDURES;

ANEMIA, SICKLE CELL; BLOOD VISCOSITY; CYTAPHERESIS; DISEASE MANAGEMENT; ERYTHROCYTES; EXCHANGE TRANSFUSION, WHOLE BLOOD; HUMANS; PLASMA EXCHANGE;

EID: 85018260419     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14154     Document Type: Note

References (23)

1. Schwartz J, Padmanabhan A, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue. J Clin Apher 2016;31:149-62.
2. Koehl B, Sommet J, Holvoet L, et al. Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia. Transfusion 2016;56:1121-8.
3. Ballas SK. From individualized treatment of sickle cell pain to precision medicine: a 40-year journey. J Clin Med Res 2016;8:357-60.
4. Rifkind S, Waisman J, Thompson R, Goldfinger D. RBC exchange pheresis for priapism in sickle cell disease. JAMA 1979;242:2317-8.
5. Kleinman S, Thompson-Breton R, Breen D, Hurviz C, Goldfinger D. Exchange red blood cell pheresis in a pediatric patient with severe complications of sickle cell anemia. Transfusion 1981;21:443-6.
6. Hebbel RP. Extracorpuscular factors in the pathogenesis of sickle cell disease. Am J Pediatr Hematol Oncol 1982;4:316-9.
7. Kleinman SH, Hurvitz CG, Goldfinger D. Use of erythrocytapheresis in the treatment of patients with sickle cell anemia. J Clin Apher 1984;2:170-6.
8. Talacki CA, Ballas SK. Modified method of exchange transfusion in sickle cell disease. J Clin Apher 1990;5:183-7.
9. Mohandas N, Evans E. Adherence of sickle erythrocytes to vascular endothelial cells: requirement for both cell membrane changes and plasma factors. Blood 1984;64:282-7.
10. Ballas SK, Burka ER, Lewis CN, Krasnow SH. Serum immunoglobulin levels in patients having sickle cell syndromes. Am J Clin Pathol 1980;73:394-6.
11. Belcher JD, Chen C, Nguyen J, et al. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood 2014;123:377-90.
12. Chen G, Zhang D, Fuchs TA, Manwani D, Wagner DD, Frenette PS. Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. Blood 2014;123:3818-27.
13. Minniti CP, Eckman J, Sebastiani P, Seeinberg MH, Ballas SK. Leg ulcers in sickle cell disease. Am J Hematol 2010;85:831-3.
14. Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 2014;312:1033-48.
15. Janes SL, Pocock M, Bishop E, Bevam DJ. Automated red cell exchange in sickle cell disease. Br J Haematol 1997;97:256-8.
16. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
17. Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005;353:2769-78.
18. Ayache S, Herman JH, Hall N, Kent T, Ballas SK. Plasma exchange may benefit acute chest syndrome in sickle cell disease. J Clin Apher 2007;22:82-3.
19. Filomena CA, Filomena AP, Hudock J, Ballas SK. Evaluation of serum immunoglobulins by protein electrophoresis and rate nephelometry before and after therapeutic plasma exchange. Am J Clin Pathol 1992;98:243-8.
20. Zhang D, Xu C, Manwani D, Frenette PS. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood 2016;127:801-9.
21. Manwani D, Frenette PS. Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Hematol Am Soc Hematol Educ Program 2013;2013:362-9.
22. Ballas S. K. Chapter 4: the acute painful episode. In: Sickle cell pain, 2nd ed. Washington (DC): International Association for the Study of Pain; 2014. p. 98.
23. Zhou Z, Han H, Cruz MA, López JA, Dong JF, Guchhait P. Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease. Thromb Haemost 2009;101:1070-7.